The epidemiology of the viral hepatitis in Brazil: A scoping review

BACKGROUND: Brazil has advanced toward eliminating viral hepatitis by 2030 through broad prevention, diagnosis, and treatment policies. Yet substantial gaps persist across the care continuum, especially in vulnerable populations and underserved regions. This scoping review synthesizes nationwide epidemiologic patterns and identifies knowledge gaps to inform policy. METHODS: We conducted a PRISMA‑guided scoping review on seven databases (2013-2024) for Portuguese/Spanish/English observational studies or systematic reviews with post‑2010 data, extracting epidemiological patterns by viral hepatitis type and population group. RESULTS: Across 200 included studies, the combined sample encompassed more than 14.5 million individuals. Hepatitis B was the most studied, followed by hepatitis C. Hepatitis A seroprevalence in general population ranged from 33.3-67.8%. In vulnerable populations, highest seroprevalence was among incarcerated populations (88.1%), followed by immigrants (87.4%) and transgender individuals (75.6%). Hepatitis B presented HBsAg prevalence ranging from 0-7.5% in the general population, with the highest rates in an endemic Amazon region. Hepatitis C seroprevalence varied from 0.04-2.2% in the general population, with higher rates among people who use drugs (36.9%). Hepatitis D was predominantly reported in the Amazon region, with prevalence ranging from 0-23.9%. For hepatitis E, prevalence in the general population ranged from 0.9-59.4%, with the highest value in the South region. CONCLUSIONS: Viral hepatitis in Brazil shows heterogeneous epidemiologic patterns across regions and populations, alongside unequal research output. The predominance of small, cross‑sectional studies and their limited integration with social determinants of health highlight the need for future research employing methodologies that address the gaps identified in this review. The resulting evidence map can guide policies aligned with national elimination goals.

Authors

Institutions

Publication Details

Journal
PLoS ONE
Published
2026-07-17
DOI
https://doi.org/10.1371/journal.pone.0353840
Primary Topic
Hepatitis Viruses Studies and Epidemiology
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The epidemiology of the viral hepatitis in Brazil: A scoping review

João Renato Rebello Pinho, Roberta Sitnik, Mário Peribañez Gonzalez, Maiko Luís Tonini et al.
PLoS ONE
Hepatitis Viruses Studies and Epidemiology
article

The epidemiology of the viral hepatitis in Brazil: A scoping review

João Renato Rebello Pinho, Roberta Sitnik, Mário Peribañez Gonzalez, Maiko Luís Tonini, Carla Francisca dos Santos Cruz, Flávia Moreno Alves de Souza, Priscilla. Robinson, Denize Ornelas Pereira Salvador de Oliveira, Maria Cecília Araripe Sucupira, Elton Carlos de Almeida, Ana Paula Maciel Gurski, Raquel Queiroz, Cesar Inoue, Bruna Emanuelle Alvarenga Fanis, Nathália Villa dos Santos, Roberta dos Santos Pereira, Ketti Gleyzer de Oliveira, Caroline Thomaz Panico, Isis Aleixo Barone Esquiçati, Sabrina David Pugliese, Thais Sena de Paula Domingues
article en

Abstract

BACKGROUND: Brazil has advanced toward eliminating viral hepatitis by 2030 through broad prevention, diagnosis, and treatment policies. Yet substantial gaps persist across the care continuum, especially in vulnerable populations and underserved regions. This scoping review synthesizes nationwide epidemiologic patterns and identifies knowledge gaps to inform policy. METHODS: We conducted a PRISMA‑guided scoping review on seven databases (2013-2024) for Portuguese/Spanish/English observational studies or systematic reviews with post‑2010 data, extracting epidemiological patterns by viral hepatitis type and population group. RESULTS: Across 200 included studies, the combined sample encompassed more than 14.5 million individuals. Hepatitis B was the most studied, followed by hepatitis C. Hepatitis A seroprevalence in general population ranged from 33.3-67.8%. In vulnerable populations, highest seroprevalence was among incarcerated populations (88.1%), followed by immigrants (87.4%) and transgender individuals (75.6%). Hepatitis B presented HBsAg prevalence ranging from 0-7.5% in the general population, with the highest rates in an endemic Amazon region. Hepatitis C seroprevalence varied from 0.04-2.2% in the general population, with higher rates among people who use drugs (36.9%). Hepatitis D was predominantly reported in the Amazon region, with prevalence ranging from 0-23.9%. For hepatitis E, prevalence in the general population ranged from 0.9-59.4%, with the highest value in the South region. CONCLUSIONS: Viral hepatitis in Brazil shows heterogeneous epidemiologic patterns across regions and populations, alongside unequal research output. The predominance of small, cross‑sectional studies and their limited integration with social determinants of health highlight the need for future research employing methodologies that address the gaps identified in this review. The resulting evidence map can guide policies aligned with national elimination goals.

PLoS ONEVol. 21(7)
Hospital Israelita Albert Einstein (BR), Department of STD, AIDS and Viral Hepatitis (BR)
Ministério da Saúde
Good health and well-being
Openalex Percentile: Top 10%
Hepatitis Viruses Studies and Epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.